×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Zymergen Ch. 11 Plan Confirmed After Investor Objection
Law360
Biotechnology company Zymergen received confirmation of its Chapter 11 plan Monday at a hearing in Delaware bankruptcy court after resolving...
3 months ago
Ginkgo Bioworks and Zymergen end IPO tale in bankruptcy
Seeking Alpha
Ginkgo Bioworks' (NYSE:DNA) announcement of Zymergen's bankruptcy filing on Tuesday highlights how the biotech IPO boom in 2021 has...
7 months ago
Layoffs: Hundreds of San Francisco Bay Area Jobs Slashed
The San Francisco Standard
Two San Francisco Bay Area biotech firms and a technology company will slash hundreds of jobs combined through early next year.
6 months ago
Dynavax Secures New Sublease Agreement Amidst Zymergen's Bankruptcy - TipRanks.com
Tipranks
An update from Dynavax Technologies Corp. (DVAX) is now available. Dynavax Technologies Corporation has transitioned from a sublease with...
1 month ago
Biotech Industry Bankruptcy Cases: 'Zymergen' and 'Humanigen' | New York Law Journal
Law.com
This issue of the Bankruptcy Update column focuses on the recent biotech industry bankruptcy cases of Zymergen and Humanigen.
1 month ago
The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPO
Forbes
Zymergen raised $500 million when it went public in April, on top of more than $1 billion in venture funding. By August, its CEO was out and...
30 months ago
7 months after announcing a pivot to drug discovery, Zymergen is acquired by Ginkgo
Fierce Biotech
Zymergen aimed to leave its well-publicized woes behind through a new-year transformation into a biotech. Now, the company has been picked...
21 months ago
Tech and biotech firms slash hundreds of Bay Area jobs as layoffs widen
The Mercury News
Tech and biotech companies have disclosed decisions to slash hundreds of jobs in the Bay Area in a fresh batch of staffing cutbacks that...
6 months ago
Ginkgo agrees to acquire Zymergen for $300m
Pharmaceutical Technology
Ginkgo Bioworks has signed a definitive agreement for the acquisition of biotechnology company Zymergen in an all-stock deal worth nearly...
21 months ago
Zymergen fate sealed with $300m Ginkgo Bioworks buyout
AgFunderNews
Zymergen will be acquired by fellow cell manufacturing company Ginkgo Bioworks for $300m, a sharp fall from Zymergen's once $3 billion...
21 months ago